DC
Dimension Capital
Dimension Capital is a seed to Series B stage investment firm. It has made 7 investments. 75% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $163.3M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MF
Miguel Fernando Duenas
Managing Partner / Chief Investment Officer
EP
Ernesto Padron
Director, Direct Investments
JF
Jonathan Fischer
Investment Analyst
AL
Alvaro Lacayo
Investment professional
AG
Adam Goulburn
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EEarendil Labs | Unknown | $787M | Jan 2026 |
 Convoke | Seed | $8.6M | Aug 2025 |
 Stately Bio | Seed | $12M | May 2025 |
 NewLimit | Series B | $130M | Jan 2025 |
| NewLimit | Series A | — | May 2023 |
 Cajal Neuroscience | Series A | $96M | Jan 2022 |
 Cajal | Series A | $96M | Jan 2022 |
 Tamarind Bio | Series A | $13.6M | — |
Top Co-Investors
Dimension5 shared
Lux Capital3 shared
Kleiner Perkins3 shared
Y Combinator2 shared
Founders Fund2 shared
Sanofi Ventures1 shared
DST Global1 shared
Luminous Ventures1 shared
Dimension Data1 shared
Dolby Family Ventures1 shared
Alexandria Venture Investments1 shared
Bristol Myers Squibb1 shared
The Column Group1 shared
Two Sigma Ventures1 shared
Human Ventures1 shared
Boost Capital Partners1 shared
Abstract Ventures1 shared
Section 321 shared
Duke Capital Partners1 shared
Khosla Ventures1 shared
Last updated: 27 September 2026